| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4759455
Max Phase: Preclinical
Molecular Formula: C20H20BrN3O5S
Molecular Weight: 494.37
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCOC(=O)N1CCc2c(sc3nc(-c4cc(Br)c(OC)c(OC)c4)[nH]c(=O)c23)C1
Standard InChI: InChI=1S/C20H20BrN3O5S/c1-4-29-20(26)24-6-5-11-14(9-24)30-19-15(11)18(25)22-17(23-19)10-7-12(21)16(28-3)13(8-10)27-2/h7-8H,4-6,9H2,1-3H3,(H,22,23,25)
Standard InChI Key: DTDPRYPGXLQTLC-UHFFFAOYSA-N
Associated Targets(Human)
KB-V1 202 Activities
HCT-116 91556 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
518A2 464 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
EA.hy 926 491 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 494.37 | Molecular Weight (Monoisotopic): 493.0307 | AlogP: 3.95 | #Rotatable Bonds: 4 |
| Polar Surface Area: 93.75 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.03 | CX Basic pKa: 0.47 | CX LogP: 3.34 | CX LogD: 3.26 |
| Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.59 | Np Likeness Score: -1.41 |
References
| 1. Gold M,Köhler L,Lanzloth C,Andronache I,Anant S,Dandawate P,Biersack B,Schobert R. (2020) Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones., 189 [PMID:31958738] [10.1016/j.ejmech.2020.112060] |
Source
Source(1):